April 20, 2022
PAR-22-145 - Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating is participating in PAR-22-145, "Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)."
The following changes (in italics) have been made to reflect NCI's participation in this FOA:
Part 1. Overview Information
Components of Participating Organizations
National Institute on Minority Health and Health Disparities (NIMHD)
National Eye Institute (NEI)
National Institute on Aging (NIA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Mental Health (NIMH)
National Library of Medicine (NLM)
National Cancer Institute (NCI)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Sexual and Gender Minority Research Office (SGMRO)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.307, 93.242, 93.879, 93.867, 93.286, 93.866, 93.393
Part 2. Full Text of Announcement
Section VII. Agency Contacts
The following contact has been added:
Scientific/Research Contacts
Heather D'Angelo, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6597
Email: [email protected]
Heather D'Angelo, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6597
Email: [email protected]